Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2772983

CCCCC(CC)CN.Cl

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 3/20 0.43
HSP90AA1 known ✓ P07900 1/20 0.41
CHRM2 known ✓ P08172 1/20 0.40
HTR1A known ✓ P08908 1/20 0.40
ADRA2A known ✓ P08913 1/20 0.40
CHRM1 known ✓ P11229 1/20 0.40
SLC6A2 known ✓ P23975 1/20 0.40
SLC6A4 known ✓ P31645 1/20 0.40
OPRM1 known ✓ P35372 1/20 0.40
DRD3 known ✓ P35462 1/20 0.40
SLC6A3 known ✓ Q01959 1/20 0.40
KCNH2 known ✓ Q12809 1/20 0.40
ALDH1A1 P00352 3/20 0.95
TDP1 Q9NUW8 2/20 0.95
CYP3A4 P08684 5/20 0.52
TSHR P16473 3/20 0.52
L3MBTL1 Q9Y468 1/20 0.43
BCL2L1 Q07817 3/20 0.41
BAK1 Q16611 3/20 0.41
USP2 O75604 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2599658 0.97
SCHEMBL28690 0.97
SCHEMBL9004577 0.97 ALDH1A1 (1.00) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL13478297 0.97
SCHEMBL1931933 0.95 ALDH1A1 (0.95) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL7205000 0.95
Bromide SCHEMBL3913876 0.95 ALDH1A1 (0.95) ALDH1A1TDP1CYP3A4TSHRCA2
Water SCHEMBL1584914 0.95 ALDH1A1 (0.95) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL6935237 0.95 ALDH1A1 (0.95) ALDH1A1TDP1CYP3A4TSHRCA2
Methylamine SCHEMBL6868280 0.95 ALDH1A1 (0.95) ALDH1A1TDP1CYP3A4TSHRCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110087823-B Flux and resin composition for flux 千住金属工业株式会社 2021-04-27 CN claimed
US-20200131431-A1 CHEMICAL ADDITIVES AND SURFACTANT COMBINATIONS FOR FAVORABLE WETTABILITY ALTERATION AND IMPROVED HYDROCARBON RECOVERY FACTORS ALCHEMY SCIENCES INC (US) 2020-04-30 US claimed
CN-104549719-B Remove the process of impurity in carbonate mineral 氰特技术公司 2018-08-07 CN claimed
CN-104549719-A Process for the removal of impurities from carbonate minerals CYTEC TECH CORP 2015-04-29 CN claimed
CN-101600507-A Process for removing impurities from carbonate minerals CYTEC TECH CORP (US) 2009-12-09 CN claimed
US-4348331-A FROM THE HYDROCHLORIDE OF A PRIMARY AMINE AND AN ARYL ESTER HALIDE BAYER AKTIENGESELLSCHAFT (DE) 1982-09-07 US claimed
US-12605794-B2 Flux and solder paste SENJU METAL INDUSTRY CO., LTD. (JP) 2026-04-21 US disclosed
US-12515281-B2 Flux SENJU METAL INDUSTRY CO., LTD. (JP) 2026-01-06 US disclosed
EP-4332257-B1 FLUX AND SOLDER PASTE SENJU METAL INDUSTRY CO (JP) 2025-10-15 EP disclosed
US-12365054-B2 Flux and solder paste SENJU METAL INDUSTRY CO., LTD. 2025-07-22 US disclosed
US-12304008-B2 Flux and method for producing assembly SENJU METAL INDUSTRY CO., LTD. (JP) 2025-05-20 US disclosed
US-12269806-B2 Flux and solder paste SENJU METAL INDUSTRY CO., LTD. (JP) 2025-04-08 US disclosed
CN-118176084-B Soldering flux and method for producing bonded body 千住金属工业株式会社 2025-03-18 CN disclosed
WO-1994026419-A1 METHOD OF FLOATING CALCIUM CARBONATE ORE AND FLOTATION REAGENT THEREFOR BEROL NOBEL AB (SE) 1994-11-24 WO disclosed
EP-0619162-A2 Soldering flux Takeda Chemical Industries, Ltd. (JP) 1994-10-12 EP disclosed
EP-0593923-A1 Water-insoluble sulfur dyes, their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1994-04-27 EP disclosed
US-5080830-A Water-dispersible compositions comprised of quaternary ammonium compounds AKZO N.V. (NL) 1992-01-14 US disclosed
US-4206215-A Antimicrobial bis-[4-(substituted-amino)-1-pyridinium]alkanes STERLING DRUG INC. (US) 1980-06-03 US disclosed
US-4130687-A VERMICULITE LEMELLAE IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1978-12-19 US disclosed
US-4107313-A α,α-Bis-[4-(R-amino)-1-pyridinium]xylenes and antibacterial and antifungal uses STERLING DRUG INC. (US) 1978-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12269806-B2 Flux and solder paste OTC, SLC25A11, PROC CA2 612/4885HSP90AA1 3741/4885CHRM2 4610/4885
US-12605794-B2 Flux and solder paste RIOK2, TRA2B, BAG2 CA2 922/4885HSP90AA1 167/4885CHRM2 2225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.